Genotype-Dependent Effects of Bifendate on Cyclosporine Phar
2026-05-31
This article analyzes the 2009 reference study demonstrating that Bifendate (DDB) significantly alters the pharmacokinetics of cyclosporine in a manner dependent on the CYP3A4*18B genotype. The findings have direct implications for the safe co-administration of hepatoprotective agents and immunosuppressants, highlighting the need for genotype-guided dosing strategies.
FPH1 (BRD-6125) for Optimized Hepatocyte Proliferation Assay
2026-05-30
FPH1 (BRD-6125) empowers researchers to scale and sustain functional human hepatocyte cultures, breaking the bottleneck of donor dependency in liver cell research. This guide details actionable experimental workflows, troubleshooting insights, and cross-validates advances in optogenetic gene regulation, positioning FPH1 as a cornerstone for next-generation cell therapy and disease modeling.
Aztreonam in Research: Beyond Gram-Negative Selectivity
2026-05-29
Unlock the scientific potential of Aztreonam, a monocyclic β-lactam antibiotic, with an in-depth exploration of its distinctive mechanisms, effects on cellular and metabolic pathways, and practical implications for resistance research. Discover advanced assay guidance built on new resistance genomics data.
NF-κB p65–YAP–NLRP3 Axis Regulates Pyroptosis in Ulcerative
2026-05-29
This study elucidates how NF-κB p65 activation in colonic epithelial cells promotes YAP inactivation, which relieves repression of NLRP3 transcription and escalates pyroptosis in ulcerative colitis. These findings reveal a mechanistic link between inflammatory signaling and cell death, opening new avenues for targeted interventions in colitis.
CD163+ Macrophage Activation Drives Granulosa Cell Apoptosis
2026-05-28
This study elucidates how increased CD163+ macrophage activation and high CD163 expression in ovarian tissue promote granulosa cell apoptosis, advancing our understanding of polycystic ovary syndrome (PCOS) pathogenesis. By integrating patient data and a DHEA-induced PCOS mouse model, the research highlights the interplay between inflammation, immune cell behavior, and impaired follicular development, with implications for future therapeutic targeting.
High-Throughput Identification of TB DHFR Inhibitors and MoA
2026-05-28
This study introduces a robust framework combining high-throughput biophysical screening and machine learning to identify mechanisms of action and novel inhibitors targeting Mycobacterium tuberculosis dihydrofolate reductase (Mtb DHFR). The approach bridges phenotypic and target-based screening, offering actionable insights for antibacterial agent discovery and resistance research.
Computational Hapten Design Enables Rapid Mushroom Toxin Det
2026-05-27
This study introduces a computational chemistry-driven strategy for hapten design, enabling the simultaneous, highly sensitive detection of amatoxins and phallotoxins in mushrooms. The resulting dual-target fluorescent immunochromatographic assay holds important implications for advancing toxicology research and improving public health monitoring.
Evaluating Drug Responses in Cancer: Improved In Vitro Appro
2026-05-27
Schwartz's dissertation introduces refined in vitro methodologies for disentangling proliferative arrest and cell death during anti-cancer drug evaluation. By distinguishing relative viability from fractional viability, the research provides clarity on drug effects and informs better experimental protocols for cancer drug testing.
Pexmetinib (ARRY-614): Applied Strategies for Cytokine Inhib
2026-05-26
Pexmetinib (ARRY-614), a dual p38 MAPK and Tie2 inhibitor from APExBIO, delivers reproducible cytokine suppression and pathway modulation for inflammation and hematologic research. This article provides experimental workflows, troubleshooting advice, and actionable insights based on the latest structural and assay data.
S-Adenosylmethionine (SAM): Precision Tools for Epigenetic a
2026-05-26
Explore S-Adenosylmethionine (Ademetionine) as a precision methyl donor in advanced epigenetic and neuropsychiatric research. This article provides assay-focused guidance, mechanistic insights, and a practical bridge between biochemical theory and translational applications.
Position 3 Modification in GnRH Antagonists: Synthesis and A
2026-05-25
This study pioneers the incorporation of 3-(2-methoxy-5-pyridyl)-alanine at position 3 in degarelix-based GnRH antagonists, revealing stereochemistry-dependent in vitro potency and in vivo duration. The findings refine structure–activity understanding for peptide-based GnRH receptor inhibitors, with implications for antagonist design in reproductive and endocrine research.
Clozapine N-oxide: Precision Chemogenetics in Circuit Mappin
2026-05-25
Clozapine N-oxide (CNO) is the gold-standard actuator for DREADD-based neuronal modulation, offering unmatched selectivity and reliability in neuroscience research. This article delivers practical guidance on optimizing CNO workflows, troubleshooting, and leveraging recent innovations in targeting complex brain regions.
Sodium Influx Drives Mitochondrial Failure in NECSO Cell Dea
2026-05-24
Qiao et al. (2025) elucidate how sodium influx, mediated by TRPM4 activation, disrupts mitochondrial energy metabolism to execute necrosis by sodium overload (NECSO). This mechanistic insight clarifies the link between ion dysregulation and mitochondrial dysfunction, informing future research on cell death and related pathologies.
GLT-1 Upregulation Reduces Neuronal Death via CB1-CREB Inhib
2026-05-23
The referenced study identifies upregulation of GLT-1 as a neuroprotective mechanism that mitigates neuronal apoptosis and cognitive deficits after traumatic brain injury by suppressing the CB1-CREB signaling pathway. These findings clarify a mechanistic link between cannabinoid signaling, glutamate homeostasis, and neuronal survival, offering new targets for memory impairment research and therapeutic intervention.
Digoxin in Translational Research: Mechanisms and Strategic
2026-05-22
This thought-leadership article explores how Digoxin, a well-known Na+/K+ ATPase pump inhibitor, is redefining the landscape of translational research. Moving beyond its established role in arrhythmia and heart failure, we delve into mechanistic and strategic insights for researchers seeking to bridge cardiovascular and antiviral domains. The discussion contextualizes Digoxin’s unique cell-type-specific antiviral activities, outlines rigorous experimental parameters, evaluates competitive benchmarks, and offers a practical outlook for translational impact.
461 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page